NovoCure Ltd (NVCR) bonds
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$11.14−0.16 (-1.42%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
NovoCure reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in NovoCure's 10-Q for the period ended Sep 30, 2026
NovoCure's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| 2024 Credit Facility | $400.00M | $195.05M |
| 2024 Credit Facility Tranche A | $200.00M | $196.34M |
| Revolving credit facility | $200.00M | $195.05M |
See a number that looks wrong?